In colorectal carcinoma, IGF2BP3 has been shown to activate the MEK1/ERK signaling pathway and promote anti-apoptotic pathways through the stabilization of Bcl-2 and Bcl-xL transcripts [67,68]. This evidence concerns the gene IGF2BP3 and colorectal carcinoma.